MARCOL
gene geneOn this page
Summary
MARCOL (MARCO like, HGNC:53644) is a protein-coding gene on chromosome 5q32, encoding MARCO-like protein (A0A1B0GUY1).
Predicted to be located in endoplasmic reticulum lumen.
Source: NCBI Gene 105378220 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001363511
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53644 |
| Approved symbol | MARCOL |
| Name | MARCO like |
| Location | 5q32 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000248109 |
| Ensembl biotype | protein_coding |
| Entrez | 105378220 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding_CDS_not_defined, 2 protein_coding
ENST00000513133, ENST00000637618, ENST00000638059, ENST00000638089
RefSeq mRNA: 1 — MANE Select: NM_001363511
NM_001363511
CCDS: CCDS87333
Canonical transcript exons
ENST00000638089 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002026672 | 148238525 | 148238646 |
| ENSE00003799862 | 148242446 | 148243580 |
Expression profiles
Bgee: expression breadth broad, 28 present calls, max score 53.20.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6313 / max 409.1955, expressed in 35 samples.
FANTOM5 promoters (13 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 59300 | 0.1321 | 17 |
| 59298 | 0.1227 | 7 |
| 59297 | 0.1077 | 7 |
| 59295 | 0.0879 | 7 |
| 59303 | 0.0585 | 18 |
| 59296 | 0.0347 | 6 |
| 59301 | 0.0277 | 16 |
| 59302 | 0.0263 | 14 |
| 59299 | 0.0125 | 6 |
| 59293 | 0.0062 | 1 |
Top tissues by expression
97 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 53.20 | gold quality |
| corpus callosum | UBERON:0002336 | 50.89 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 40.24 | silver quality |
| ganglionic eminence | UBERON:0004023 | 39.64 | silver quality |
| endocervix | UBERON:0000458 | 39.13 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 38.50 | gold quality |
| prostate gland | UBERON:0002367 | 37.86 | gold quality |
| muscle tissue | UBERON:0002385 | 37.30 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.70 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 35.85 | gold quality |
| sural nerve | UBERON:0015488 | 35.33 | gold quality |
| tonsil | UBERON:0002372 | 34.65 | gold quality |
| liver | UBERON:0002107 | 34.42 | gold quality |
| myometrium | UBERON:0001296 | 34.41 | gold quality |
| urinary bladder | UBERON:0001255 | 33.65 | gold quality |
| primary visual cortex | UBERON:0002436 | 33.53 | gold quality |
| left uterine tube | UBERON:0001303 | 33.51 | gold quality |
| calcaneal tendon | UBERON:0003701 | 33.35 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 32.95 | gold quality |
| cortex of kidney | UBERON:0001225 | 32.74 | silver quality |
| left adrenal gland cortex | UBERON:0035825 | 32.45 | gold quality |
| prefrontal cortex | UBERON:0000451 | 32.38 | gold quality |
| uterine cervix | UBERON:0000002 | 32.22 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| ovary | UBERON:0000992 | 31.79 | silver quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.79 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Marcol | ENSMUSG00000110628 |
| rattus_norvegicus | Gm37797 | ENSRNOG00000067712 |
Protein
Protein identifiers
MARCO-like protein — A0A1B0GUY1 (reviewed: A0A1B0GUY1)
All UniProt accessions (2): A0A1B0GUY1, A0A1B0GTV2
RefSeq proteins (1): NP_001350440* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR050938 | Collagen_Structural_Proteins | Family |
UniProt features (13 total): compositionally biased region 8, region of interest 2, signal peptide 1, chain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GUY1-F1 | 41.77 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 24
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 11 (showing top):
chr5q32, GOCC_ENDOPLASMIC_RETICULUM_LUMEN, CEBPE_TARGET_GENES, EMX1_TARGET_GENES, FEV_TARGET_GENES, NFE2L1_TARGET_GENES, NR1D1_TARGET_GENES, RORA_TARGET_GENES, NKX2_5_TARGET_GENES, DBP_TARGET_GENES, INSM2_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): endoplasmic reticulum lumen (GO:0005788)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| endoplasmic reticulum | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
226 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MARCOL | MED20 | Q9H944 | 325 |
| MARCOL | MSR1 | P21757 | 299 |
| MARCOL | SCARA5 | Q6ZMJ2 | 271 |
| MARCOL | TSPO | P30536 | 189 |
| MARCOL | SCARB2 | Q14108 | 172 |
| MARCOL | GNRH1 | P01148 | 151 |
| MARCOL | SCARA3 | Q6AZY7 | 146 |
| MARCOL | COLEC12 | Q5KU26 | 145 |
| MARCOL | UNC79 | Q9P2D8 | 125 |
| MARCOL | MARCO | Q9UEW3 | 122 |
| MARCOL | RAB14 | P35287 | 121 |
| MARCOL | DPY30 | Q9C005 | 92 |
| MARCOL | RBBP5 | Q15291 | 91 |
| MARCOL | ASH2L | Q9UBL3 | 91 |
| MARCOL | MED10 | Q9BTT4 | 88 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GUY1, A6NJ88, A6QL64, B3KS81, E9Q6E9, O43493, O48582, O77733, P04279, P0C7A4, P0C7A5, P0CV57, P0DKJ7, P10322, P16225, P48997, P48998, Q02383, Q06990, Q08AG5, Q0ZNK1, Q5JPF3, Q5JRC9, Q5SRN2, Q5U7M7, Q5U7M8, Q5U7M9, Q5U7N0, Q5U7N1, Q5U7N3, Q5U7N4, Q5XHX6, Q659K0, Q6AYN3, Q6JHY2, Q6P902, Q6SJ82, Q6X2M3, Q6XPR3, Q80Y39
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1835 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:148238640:T:C | F15L | 0.624 |
| 5:148238642:C:A | F15L | 0.624 |
| 5:148238642:C:G | F15L | 0.624 |
| 5:148242478:T:C | F28L | 0.582 |
| 5:148242480:C:A | F28L | 0.582 |
| 5:148242480:C:G | F28L | 0.582 |
dbSNP variants (sampled 300 via entrez): RS1000189209 (5:148242016 C>G), RS1000204680 (5:148238712 G>A,C,T), RS1000342638 (5:148236553 T>G), RS1001040384 (5:148243437 T>C), RS1001661710 (5:148239387 A>G), RS1001917085 (5:148240920 G>A), RS1002381723 (5:148237511 C>G), RS1002437926 (5:148243990 C>T), RS1002530835 (5:148238280 C>T), RS1002581331 (5:148243904 A>G,T), RS1002937471 (5:148238045 G>A), RS1003068061 (5:148240766 G>A), RS10037138 (5:148236810 A>G,T), RS1004151671 (5:148240140 C>T), RS10042764 (5:148238871 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sulforaphane | decreases expression | 1 |
| licochalcone B | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.